22nd Century Announces 1-for-135 Reverse Stock SplitMocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (
NASDAQXXII), a tobacco products company that...
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in CigarettesMocksville, North Carolina--(Newsfile Corp. - December 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that...
22nd Century Group Reports Third Quarter 2024 Financial ResultsCommencing Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple CategoriesMocksville, North Carolina--(Newsfile Corp. - November 12, 2024)...
22nd Century Group Inc. (NASDAQ: XXII) Near the Top of Equities by Percentage Gain on 4/522nd Century Group, Inc. (
NASDAQXXII) is one of today’s top gainers. The company’s shares have moved 55.76% on the day to $2.3.
22nd Century Secures $3.2 Million to Date in Warrant Exchange TransactionNewly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs
22nd Century Group Inc. (NASDAQ: XXII) Near the Top of Equities by Percentage Gain on 7/2122nd Century Group, Inc. (
NASDAQXXII) is one of today’s top gainers. The company’s shares are currently up 49.84% on the day to $5.54.
22nd Century Appoints Larry Firestone as Chairman and CEOTurnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco Assets
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis FranchiseSale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash Requirements
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology LicenseAdditional Exclusive License with NCSU Further Expands Reduced Nicotine Content Plant Breeding Capabilities
22nd Century Group (XXII) Reports Third Quarter 2023 Financial ResultsBUFFALO, N.Y., Nov. 06, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today reported results for the third quarter ended September 30, 2023, and provided an update on recent business highlights.
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMBBUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it supports the recent move by the US Food and Drug Administration to send final rules aimed at banning menthol in cigarettes and banning flavored cigars to the White House Office of Management and Budget for review, a key regulatory step toward the rules becoming federal policy.
22nd Century Group (XXII) Reduces Debt by $8.1 Million37% Reduction Through the Transfer of Non-Core and Previously Restricted Assets
22nd Century Announces Pricing of $5.25 Million Public OfferingBUFFALO, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced the pricing of its previously announced public offering of 10,000,000 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 20,000,000 shares of common stock, at a combined public offering price of $0.525 per share (or common stock equivalent in lieu thereof) and accompanying warrants. The warrants have an exercise price of $0.525 per share, are immediately exercisable and will expire five years following the date of issuance. The offering is expected to close on or about October 19, 2023, subject to the satisfaction of customary closing conditions.
22nd Century Announces Proposed Public OfferingBUFFALO, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it intends to offer and sell in a “best efforts” public offering shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock. All of the shares of common stock (or common stock equivalents) and warrants in the offering are to be offered by the Company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five StatesFirst Drug Store Channel Retail Chain Begins VLN® Sales in September, Continues to Book Additional Launches for Rest of 2023
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco AssetsBUFFALO, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (
NASDAQXXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company’s tobacco assets. The process will include consideration of a range of strategic, operational and financial transactions and alternatives, such as business combinations, asset sales, licensing agreements, alternate financing strategies and other options.
22nd Century Group (XXII) Reports Second Quarter 2023 Financial ResultsBUFFALO, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today reported results for the Second quarter ended June 30, 2023, and provided an update on recent business highlights. The Company will host a live audio webcast today at 8:00 a.m. ET.
22nd Century Group (XXII) Updates Second Quarter 2023 Results Webcast Time on August 14, 2023BUFFALO, N.Y., Aug. 09, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at a revised time of 8:00 AM ET to discuss its 2023 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023BUFFALO, N.Y., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at 10:00 AM ET to discuss its 2023 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
22nd Century Announces Executive Leadership ChangesExpands Board with New Highly Accomplished Independent Director
22nd Century Group (XXII) Regains Compliance with Nasdaq Listing StandardsBUFFALO, N.Y., July 20, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced notification that it has regained compliance with Nasdaq listing requirements.
Global E-Cigarette Market Estimated to Grow to $168 Billion by 2030EQNX::TICKER_START (
NASDAQXXII),
NYSE:BTINYSEBTI)
(NYSE:MONYSEMO
,(NYSE:PMNYSE
),(OTCQX:IMBBY) EQNX::TICKER_END
22nd Century Group (XXII) VLN® Products Now Selling in Montana C-StoresTown Pump, #1 Chain in Montana, Selling VLN® Products in More Than 80 Stores Across the State
